1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Denisov, A.Y. Madiraju, M.S. Chen, G. Khadir, A. Beauparlant, P. Attardo, G. Shore, G.C. Gehring, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.BIOL.CHEM. JBCHA3 0071 0021-9258 278 21124 21128 10.1074/jbc.M301798200 12651847 Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix 2003 10.2210/pdb1mk3/pdb pdb_00001mk3 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 19659.885 Apoptosis regulator Bcl-W P116V 1 man polymer Bcl-w no no ATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQ VSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEVLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEARR LREGNWASVRLEHHHHHH ATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQ VSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEVLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEARR LREGNWASVRLEHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample 9606 Homo sapiens 511693 Escherichia coli BL21 BL21 pET-29b+ database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2003-06-03 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details RCSB Y RCSB 2002-08-28 REL REL The structure was determined using triple-resonance NMR spectroscopy structures with the least restraint violations,structures with the lowest energy 200 10 HNCACB CBCA(CO)HN 13C,15N-edited NOESY HNCO 15N-edited NOESY HNHA IPAP-HSQC 10 mM NaCl 7.3 1 atm 298 K Structure refined by using standard protocol in CNS with restraints from NOE distances, backbone torsion angles, hydrogen bonds and residual dipolar couplings simulated annealing 1 closest to the average,lowest energy 1.4 mM Bcl-w protein U-15N,13C, 20 mM phosphate buffer 90% H2O/10% D2O 1.3 mM Bcl-w protein U-15N, 20 mM phosphate buffer 90% H2O/10% D2O 0.5 mM Bcl-w protein U-15N, 6 MG/ML PF1-PHAGE 90% H2O/10% D2O Brunger collection CNS Brunger processing CNS Brunger data analysis CNS Brunger et al. refinement CNS 1.1 500 Bruker DRX 800 Varian INOVA ALA 1 n 1 ALA 1 A THR 2 n 2 THR 2 A PRO 3 n 3 PRO 3 A ALA 4 n 4 ALA 4 A SER 5 n 5 SER 5 A ALA 6 n 6 ALA 6 A PRO 7 n 7 PRO 7 A ASP 8 n 8 ASP 8 A THR 9 n 9 THR 9 A ARG 10 n 10 ARG 10 A ALA 11 n 11 ALA 11 A LEU 12 n 12 LEU 12 A VAL 13 n 13 VAL 13 A ALA 14 n 14 ALA 14 A ASP 15 n 15 ASP 15 A PHE 16 n 16 PHE 16 A VAL 17 n 17 VAL 17 A GLY 18 n 18 GLY 18 A TYR 19 n 19 TYR 19 A LYS 20 n 20 LYS 20 A LEU 21 n 21 LEU 21 A ARG 22 n 22 ARG 22 A GLN 23 n 23 GLN 23 A LYS 24 n 24 LYS 24 A GLY 25 n 25 GLY 25 A TYR 26 n 26 TYR 26 A VAL 27 n 27 VAL 27 A CYS 28 n 28 CYS 28 A GLY 29 n 29 GLY 29 A ALA 30 n 30 ALA 30 A GLY 31 n 31 GLY 31 A PRO 32 n 32 PRO 32 A GLY 33 n 33 GLY 33 A GLU 34 n 34 GLU 34 A GLY 35 n 35 GLY 35 A PRO 36 n 36 PRO 36 A ALA 37 n 37 ALA 37 A ALA 38 n 38 ALA 38 A ASP 39 n 39 ASP 39 A PRO 40 n 40 PRO 40 A LEU 41 n 41 LEU 41 A HIS 42 n 42 HIS 42 A GLN 43 n 43 GLN 43 A ALA 44 n 44 ALA 44 A MET 45 n 45 MET 45 A ARG 46 n 46 ARG 46 A ALA 47 n 47 ALA 47 A ALA 48 n 48 ALA 48 A GLY 49 n 49 GLY 49 A ASP 50 n 50 ASP 50 A GLU 51 n 51 GLU 51 A PHE 52 n 52 PHE 52 A GLU 53 n 53 GLU 53 A THR 54 n 54 THR 54 A ARG 55 n 55 ARG 55 A PHE 56 n 56 PHE 56 A ARG 57 n 57 ARG 57 A ARG 58 n 58 ARG 58 A THR 59 n 59 THR 59 A PHE 60 n 60 PHE 60 A SER 61 n 61 SER 61 A ASP 62 n 62 ASP 62 A LEU 63 n 63 LEU 63 A ALA 64 n 64 ALA 64 A ALA 65 n 65 ALA 65 A GLN 66 n 66 GLN 66 A LEU 67 n 67 LEU 67 A HIS 68 n 68 HIS 68 A VAL 69 n 69 VAL 69 A THR 70 n 70 THR 70 A PRO 71 n 71 PRO 71 A GLY 72 n 72 GLY 72 A SER 73 n 73 SER 73 A ALA 74 n 74 ALA 74 A GLN 75 n 75 GLN 75 A GLN 76 n 76 GLN 76 A ARG 77 n 77 ARG 77 A PHE 78 n 78 PHE 78 A THR 79 n 79 THR 79 A GLN 80 n 80 GLN 80 A VAL 81 n 81 VAL 81 A SER 82 n 82 SER 82 A ASP 83 n 83 ASP 83 A GLU 84 n 84 GLU 84 A LEU 85 n 85 LEU 85 A PHE 86 n 86 PHE 86 A GLN 87 n 87 GLN 87 A GLY 88 n 88 GLY 88 A GLY 89 n 89 GLY 89 A PRO 90 n 90 PRO 90 A ASN 91 n 91 ASN 91 A TRP 92 n 92 TRP 92 A GLY 93 n 93 GLY 93 A ARG 94 n 94 ARG 94 A LEU 95 n 95 LEU 95 A VAL 96 n 96 VAL 96 A ALA 97 n 97 ALA 97 A PHE 98 n 98 PHE 98 A PHE 99 n 99 PHE 99 A VAL 100 n 100 VAL 100 A PHE 101 n 101 PHE 101 A GLY 102 n 102 GLY 102 A ALA 103 n 103 ALA 103 A ALA 104 n 104 ALA 104 A LEU 105 n 105 LEU 105 A CYS 106 n 106 CYS 106 A ALA 107 n 107 ALA 107 A GLU 108 n 108 GLU 108 A SER 109 n 109 SER 109 A VAL 110 n 110 VAL 110 A ASN 111 n 111 ASN 111 A LYS 112 n 112 LYS 112 A GLU 113 n 113 GLU 113 A MET 114 n 114 MET 114 A GLU 115 n 115 GLU 115 A VAL 116 n 116 VAL 116 A LEU 117 n 117 LEU 117 A VAL 118 n 118 VAL 118 A GLY 119 n 119 GLY 119 A GLN 120 n 120 GLN 120 A VAL 121 n 121 VAL 121 A GLN 122 n 122 GLN 122 A GLU 123 n 123 GLU 123 A TRP 124 n 124 TRP 124 A MET 125 n 125 MET 125 A VAL 126 n 126 VAL 126 A ALA 127 n 127 ALA 127 A TYR 128 n 128 TYR 128 A LEU 129 n 129 LEU 129 A GLU 130 n 130 GLU 130 A THR 131 n 131 THR 131 A ARG 132 n 132 ARG 132 A LEU 133 n 133 LEU 133 A ALA 134 n 134 ALA 134 A ASP 135 n 135 ASP 135 A TRP 136 n 136 TRP 136 A ILE 137 n 137 ILE 137 A HIS 138 n 138 HIS 138 A SER 139 n 139 SER 139 A SER 140 n 140 SER 140 A GLY 141 n 141 GLY 141 A GLY 142 n 142 GLY 142 A TRP 143 n 143 TRP 143 A ALA 144 n 144 ALA 144 A GLU 145 n 145 GLU 145 A PHE 146 n 146 PHE 146 A THR 147 n 147 THR 147 A ALA 148 n 148 ALA 148 A LEU 149 n 149 LEU 149 A TYR 150 n 150 TYR 150 A GLY 151 n 151 GLY 151 A ASP 152 n 152 ASP 152 A GLY 153 n 153 GLY 153 A ALA 154 n 154 ALA 154 A LEU 155 n 155 LEU 155 A GLU 156 n 156 GLU 156 A GLU 157 n 157 GLU 157 A ALA 158 n 158 ALA 158 A ARG 159 n 159 ARG 159 A ARG 160 n 160 ARG 160 A LEU 161 n 161 LEU 161 A ARG 162 n 162 ARG 162 A GLU 163 n 163 GLU 163 A GLY 164 n 164 GLY 164 A ASN 165 n 165 ASN 165 A TRP 166 n 166 TRP 166 A ALA 167 n 167 ALA 167 A SER 168 n 168 SER 168 A VAL 169 n 169 VAL 169 A ARG 170 n 170 ARG 170 A LEU 171 n 171 LEU 171 A GLU 172 n 172 GLU 172 A HIS 173 n 173 HIS 173 A HIS 174 n 174 HIS 174 A HIS 175 n 175 HIS 175 A HIS 176 n 176 HIS 176 A HIS 177 n 177 HIS 177 A HIS 178 n 178 HIS 178 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A HA HD11 GLN LEU 75 105 1.33 3 A A O H PHE GLY 86 89 1.58 5 A A HB2 HG2 PHE ARG 86 94 1.26 5 A A O H VAL GLU 110 113 1.59 5 A A O H PHE GLY 86 89 1.59 6 A A H HE SER ARG 73 77 1.25 6 A A HB3 HB3 ARG ARG 55 159 1.32 6 A A HB2 HG3 PHE ARG 86 94 1.33 6 A A O HG1 ALA THR 127 131 1.58 6 A A O H VAL GLU 110 113 1.59 7 A A HH12 HA ARG ARG 94 162 1.21 7 A A HG3 H ARG ARG 159 160 1.34 8 A A HB3 HB3 ARG ARG 55 159 1.22 8 A A HH21 HG2 ARG ARG 55 162 1.22 8 A A HA HD23 PHE LEU 146 149 1.34 10 A A O H PHE GLY 86 89 1.57 1 A PRO 7 -51.72 176.07 1 A PRO 40 -70.47 43.26 1 A PHE 56 -86.68 -135.88 1 A ARG 57 -139.57 -77.45 1 A PHE 60 -65.03 -71.03 1 A ALA 64 -65.57 -71.92 1 A HIS 68 -59.21 -75.01 1 A THR 70 -50.90 108.69 1 A ALA 74 -72.72 -155.63 1 A GLN 87 -46.90 81.92 1 A PRO 90 -71.82 40.50 1 A ALA 97 -75.50 -74.48 1 A MET 114 -100.48 43.36 1 A ARG 160 -39.19 -34.21 1 A SER 168 -70.88 25.77 1 A LEU 171 -122.97 -162.26 1 A HIS 173 -63.73 -171.15 2 A PRO 3 -51.74 109.65 2 A PRO 7 -51.72 104.95 2 A TYR 26 -145.53 -61.99 2 A PRO 36 -53.49 107.41 2 A PRO 40 -68.58 15.68 2 A PHE 56 -91.28 -139.63 2 A ARG 57 -140.47 -75.95 2 A PHE 60 -56.86 -70.80 2 A ASP 62 -55.30 -74.34 2 A HIS 68 -52.21 -73.36 2 A THR 70 -54.71 108.13 2 A PRO 71 -49.51 102.16 2 A ALA 74 -71.12 -154.17 2 A GLN 87 -47.06 81.89 2 A PRO 90 -71.88 39.10 2 A PHE 101 -63.16 -71.99 2 A LYS 112 -66.43 1.67 2 A MET 114 -100.73 44.92 2 A THR 131 -78.98 -73.86 2 A TYR 150 -89.45 32.57 2 A SER 168 -66.46 14.60 2 A HIS 174 -108.33 -167.73 2 A HIS 177 -116.62 -169.29 3 A PRO 3 -53.55 -75.67 3 A VAL 27 -56.49 91.18 3 A PHE 56 -92.01 -145.37 3 A ARG 57 -140.23 -78.18 3 A PHE 60 -39.50 -71.52 3 A ASP 62 -59.02 -74.79 3 A ALA 64 -59.36 -71.83 3 A HIS 68 -54.60 -73.38 3 A VAL 69 -29.73 -65.02 3 A THR 70 -50.28 109.78 3 A PRO 71 -49.39 101.88 3 A ALA 74 -72.21 -149.55 3 A GLN 87 -46.08 81.54 3 A PRO 90 -71.01 44.59 3 A ALA 97 -67.54 -70.70 3 A PHE 98 -39.80 -33.99 3 A THR 131 -78.98 -73.98 3 A TYR 150 -89.73 30.00 3 A ARG 159 -53.20 -73.35 3 A ARG 160 -39.59 -32.98 4 A VAL 13 -63.71 -70.18 4 A VAL 17 -68.35 -70.35 4 A ALA 30 -124.35 -69.56 4 A ALA 38 -86.79 37.94 4 A LEU 41 -68.15 -70.01 4 A PHE 56 -92.08 -141.33 4 A ARG 57 -140.70 -90.20 4 A SER 61 -56.71 -75.10 4 A HIS 68 -51.68 -72.00 4 A THR 70 -45.18 108.73 4 A PRO 71 -51.79 104.19 4 A ALA 74 -70.03 -153.59 4 A GLN 87 -42.26 81.58 4 A PRO 90 -72.34 33.19 4 A ALA 97 -66.68 -72.49 4 A LYS 112 -63.99 4.88 4 A MET 114 -99.78 42.69 4 A THR 131 -78.64 -73.09 4 A ARG 159 -56.86 -76.00 4 A ARG 160 -38.66 -32.45 4 A HIS 174 -56.42 -174.68 5 A PRO 32 -70.77 28.16 5 A PRO 40 -70.25 41.31 5 A PHE 56 -91.88 -142.73 5 A ARG 57 -141.63 -91.08 5 A PHE 60 -39.18 -70.40 5 A VAL 69 -29.47 -63.40 5 A THR 70 -49.86 108.31 5 A PRO 71 -54.15 91.94 5 A ALA 74 -67.71 -151.83 5 A GLN 87 -43.24 81.22 5 A PRO 90 -68.90 39.24 5 A VAL 110 -57.82 -71.03 5 A MET 114 -107.05 60.34 5 A THR 131 -83.56 -70.02 5 A TYR 150 -91.54 36.21 5 A GLU 157 -59.96 -74.19 5 A ARG 159 -51.14 -79.77 5 A ARG 170 -59.68 -176.23 6 A PRO 3 -52.83 -168.92 6 A ALA 6 -116.18 69.68 6 A VAL 27 -59.97 93.05 6 A ALA 30 -103.06 -166.33 6 A PHE 56 -89.18 -140.31 6 A ARG 57 -135.89 -82.29 6 A ARG 58 -117.63 62.91 6 A ASP 62 -63.92 -71.19 6 A HIS 68 -66.81 -76.86 6 A VAL 69 -29.56 -58.78 6 A ALA 74 -70.48 -156.53 6 A GLN 87 -44.85 82.22 6 A PRO 90 -69.84 40.08 6 A MET 114 -104.17 58.88 6 A SER 168 -69.49 21.43 6 A VAL 169 -46.07 98.06 6 A ARG 170 -81.22 -81.66 7 A PRO 3 -52.95 103.05 7 A PRO 7 -51.13 177.04 7 A GLU 34 -90.96 50.48 7 A ALA 38 -78.86 23.40 7 A PRO 40 -68.70 90.43 7 A PHE 56 -88.49 -140.98 7 A ARG 57 -141.65 -74.79 7 A PHE 60 -44.99 -70.39 7 A VAL 69 -29.95 -66.61 7 A THR 70 -41.68 109.84 7 A PRO 71 -49.48 95.70 7 A ALA 74 -69.69 -151.47 7 A GLN 87 -46.02 82.22 7 A MET 114 -102.46 55.27 7 A SER 168 -82.57 36.67 7 A HIS 175 -61.17 -163.19 7 A HIS 177 -58.75 107.62 8 A PHE 56 -89.03 -137.91 8 A ARG 57 -136.81 -61.36 8 A PHE 60 -66.57 -70.16 8 A HIS 68 -61.64 -79.39 8 A SER 73 -69.40 -173.76 8 A ALA 74 -67.77 -156.76 8 A GLN 87 -40.34 80.80 8 A PRO 90 -73.29 34.46 8 A ALA 97 -67.56 -70.24 8 A PHE 101 -61.52 -74.82 8 A MET 114 -101.91 52.04 8 A SER 168 -63.13 2.56 8 A VAL 169 -81.38 38.16 9 A PRO 7 -51.28 105.07 9 A GLN 23 -72.32 20.44 9 A PHE 56 -90.80 -138.87 9 A ARG 57 -139.61 -72.98 9 A THR 59 -39.90 -31.19 9 A ASP 62 -68.91 -70.15 9 A HIS 68 -62.18 -75.02 9 A PRO 71 -56.13 91.37 9 A ALA 74 -67.61 -159.45 9 A GLN 87 -45.16 82.18 9 A PRO 90 -69.11 52.10 9 A MET 114 -100.72 41.67 9 A THR 131 -79.81 -71.62 9 A GLU 157 -59.28 -71.37 9 A ARG 159 -50.02 -78.51 9 A ARG 160 -39.55 -31.81 9 A SER 168 -67.62 14.60 9 A HIS 173 -63.47 -168.91 9 A HIS 176 -53.12 105.37 10 A PRO 32 -71.48 30.05 10 A PRO 40 -69.24 3.25 10 A PHE 56 -91.51 -143.37 10 A ARG 57 -140.70 -81.83 10 A PHE 60 -42.28 -70.80 10 A VAL 69 -29.89 -63.69 10 A THR 70 -54.51 107.00 10 A PRO 71 -50.05 92.23 10 A ALA 74 -67.02 -153.75 10 A GLN 87 -43.92 80.97 10 A PRO 90 -70.79 43.70 10 A ALA 97 -70.94 -70.53 10 A MET 114 -100.71 53.55 10 A THR 131 -79.64 -73.21 10 A TYR 150 -90.20 35.10 10 A GLU 157 -62.59 -71.40 10 A ARG 159 -53.39 -77.58 10 A HIS 174 -106.72 -167.30 SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN 1 N N A ASP 8 A ASP 8 HELX_P A GLN 23 A GLN 23 1 1 16 A PRO 40 A PRO 40 HELX_P A PHE 56 A PHE 56 1 2 17 A ARG 58 A ARG 58 HELX_P A THR 70 A THR 70 1 3 13 A ALA 74 A ALA 74 HELX_P A GLN 87 A GLN 87 1 4 14 A TRP 92 A TRP 92 HELX_P A LYS 112 A LYS 112 1 5 21 A MET 114 A MET 114 HELX_P A ARG 132 A ARG 132 1 6 19 A LEU 133 A LEU 133 HELX_P A GLY 141 A GLY 141 1 7 9 A GLY 142 A GLY 142 HELX_P A ALA 148 A ALA 148 1 8 7 A ALA 154 A ALA 154 HELX_P A SER 168 A SER 168 1 9 15 APOPTOSIS Bcl-w protein, apoptotis, APOPTOSIS BCLW_HUMAN UNP 1 1 Q92843 MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFT QVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEAR RLREGNWASVR 2 171 1MK3 1 170 Q92843 A 1 1 170 1 PRO engineered mutation VAL 116 1MK3 A Q92843 UNP 117 116 1 expression tag LEU 171 1MK3 A Q92843 UNP 171 1 expression tag GLU 172 1MK3 A Q92843 UNP 172 1 expression tag HIS 173 1MK3 A Q92843 UNP 173 1 expression tag HIS 174 1MK3 A Q92843 UNP 174 1 expression tag HIS 175 1MK3 A Q92843 UNP 175 1 expression tag HIS 176 1MK3 A Q92843 UNP 176 1 expression tag HIS 177 1MK3 A Q92843 UNP 177 1 expression tag HIS 178 1MK3 A Q92843 UNP 178